Huang-Chun Lien

Affiliations: 
Pathology National Taiwan University College of Medicine, Taipei City, Taiwan 
Google:
"Huang-Chun Lien"
Bio:

Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, et al. (2020) The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice. The Journal of Pathology
Lien HC, Lee YH, Juang YL, et al. (2019) Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia. Pathology
Kuo SH, Lo C, Chen YH, et al. (2018) Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery. Clinical Breast Cancer
Lai SF, Chen YH, Liang TH, et al. (2018) The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation. Journal of Neuro-Oncology
Hsieh MS, Lien HC, Hua SF, et al. (2016) Clear cell hidradenoma of the breast with MAML2 gene rearrangement. Pathology
Fan LC, Jeng YM, Lu YT, et al. (2016) SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer. Plos One. 11: e0162933
Lai SF, Chen YH, Kuo WH, et al. (2016) Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy. Annals of Surgical Oncology
Lien HC, Huang CS, Yang YW, et al. (2016) MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Yang CC, LaBaff A, Wei Y, et al. (2015) Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers. American Journal of Translational Research. 7: 1009-20
Lien HC, Huang CS, Yang YW, et al. (2015) Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis. Histopathology
See more...